Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parbeer Grewal

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Cutaneous Medicine and Surgery|March 22, 2007
Acrokeratosis paraneoplastica (Bazex syndrome) presenting in a patient with metastatic breast carcinoma: possible etiologic role of zincMuba Taher, Parbeer Grewal, Beth Gunn, et al.
Journal of Drugs in Dermatology : JDD|February 4, 2021
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis SurveyMelinda Gooderham, Kim Papp, Lorne Albrecht, et al.
Journal of Cutaneous Medicine and Surgery|October 23, 2013
Erythema induratum: case series illustrating the utility of the interferon-γ release assay in determining the association with tuberculosisVimal Prajapati, McKay Steed, Parbeer Grewal, et al.
Journal of Cutaneous Medicine and Surgery|November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic DermatitisMelinda J Gooderham, Robert Bissonnette, Parbeer Grewal, et al.
Journal of the American Academy of Dermatology|March 21, 2021
Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitisJoseph F Merola, Jerry Bagel, Peter Almgren, et al.
Dermatology and Therapy|April 16, 2026
Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS)Jensen Yeung, Parbeer Grewal, Perla Lansang, et al.
Journal of Cutaneous Medicine and Surgery|June 6, 2020
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus PaperJensen Yeung, Melinda J Gooderham, Parbeer Grewal, et al.
Journal of the American Academy of Dermatology|January 26, 2025
Real-world experience of tralokinumab for atopic dermatitis: A 16-week multicenter retrospective studySiddhartha Sood, Marni Wiseman, Ahmed Bagit, et al.
Dermatologic Therapy|August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paperJensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
Journal of Cutaneous Medicine and Surgery|December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 PathwayWei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Cutaneous Medicine and Surgery|March 22, 2007
Acrokeratosis paraneoplastica (Bazex syndrome) presenting in a patient with metastatic breast carcinoma: possible etiologic role of zincMuba Taher, Parbeer Grewal, Beth Gunn, et al.
Journal of Drugs in Dermatology : JDD|February 4, 2021
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis SurveyMelinda Gooderham, Kim Papp, Lorne Albrecht, et al.
Journal of Cutaneous Medicine and Surgery|October 23, 2013
Erythema induratum: case series illustrating the utility of the interferon-γ release assay in determining the association with tuberculosisVimal Prajapati, McKay Steed, Parbeer Grewal, et al.
Journal of Cutaneous Medicine and Surgery|November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic DermatitisMelinda J Gooderham, Robert Bissonnette, Parbeer Grewal, et al.
Journal of the American Academy of Dermatology|March 21, 2021
Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitisJoseph F Merola, Jerry Bagel, Peter Almgren, et al.
Dermatology and Therapy|April 16, 2026
Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS)Jensen Yeung, Parbeer Grewal, Perla Lansang, et al.
Journal of Cutaneous Medicine and Surgery|June 6, 2020
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus PaperJensen Yeung, Melinda J Gooderham, Parbeer Grewal, et al.
Journal of the American Academy of Dermatology|January 26, 2025
Real-world experience of tralokinumab for atopic dermatitis: A 16-week multicenter retrospective studySiddhartha Sood, Marni Wiseman, Ahmed Bagit, et al.
Dermatologic Therapy|August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paperJensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
Journal of Cutaneous Medicine and Surgery|December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 PathwayWei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Pageof 3